Charlotte Pawlyn (C Pawlyn)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 27

Top Venues

Blood cancer journal

British journal of haematology

Leukemia

Blood

Institute of Cancer Research

Institute of Cancer Research (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Cancer Research Sep 4o 2017

United Kingdom

NIHR Clinical Lecturer :: Cancer Therapeutics

Education History

Institute of Cancer Research Aug 1o 2013 - Aug 1o 2016

United Kingdom

PHD :: Cancer Biology

Publications

Sarah Anne Bird, Charlotte Pawlyn
IMiD Resistance in Multiple Myeloma: Current Understanding of the Underpinning Biology and Clinical Impact. Blood (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Aikaterini Panopoulou, David A Cairns, Amy Elizabeth Holroyd, Isabel Nichols, Nikita Cray, Charlotte Pawlyn, Curly T C M Morris, Mark T Drayson, Kevin D Boyd, Faith E Davies, Matthew W Jenner, Gareth J Morgan, Roger G Owen, Richard S Houlston, Graham H Jackson, Martin F Kaiser
Optimizing the value of lenalidomide maintenance by genetic profiling - an analysis of 556 Myeloma XI trial patients. Blood (2022)
Ruth M de Tute, Charlotte Pawlyn, David A Cairns, Faith E Davies, Tom Menzies, Andrew C Rawstron, John R Jones, Anna Hockaday, Rowena Henderson, Curly T C M Morris, Mark T Drayson, Matthew W Jenner, Martin F Kaiser, Walter M Gregory, Gareth J Morgan, Graham H Jackson, Roger G Owen
Minimal Residual Disease After Autologous Stem-Cell Transplant for Patients With Myeloma: Prognostic Significance and the Impact of Lenalidomide Maintenance and Molecular Risk. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (25) (2022)
Faith E Davies, Charlotte Pawlyn, Saad Z Usmani, Jesús San F Miguel, Hermann Einsele, Eileen Mary Boyle, Jill Corre, Daniel Auclair, Hearn Jay Cho, Sagar Lonial, Pieter Sonneveld, A Keith Stewart, Peter Leif Bergsagel, Martin F Kaiser, Katja Weisel, Jonathan J Keats, Joseph R Mikhael, Kathryn E Morgan, Irene M Ghobrial, Robert Z Orlowski, Carl Ola Landgren, Francesca Gay, Joseph Caers, Wee-Joo Chng, Ajai Chari, Brian A Walker, Shaji K Kumar, Luciano José Megale Costa, Kenneth C Anderson, Gareth J Morgan
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma. Blood cancer discovery 3 (4) (2022)
Aikaterini Panopoulou, David A Cairns, Amy Elizabeth Holroyd, Isabel Nichols, Nikita Cray, Charlotte Pawlyn, Curly T C M Morris, Mark T Drayson, Kevin D Boyd, Faith E Davies, Matthew W Jenner, Gareth J Morgan, Roger G Owen, Richard S Houlston, Graham H Jackson, Martin F Kaiser
Optimizing the value of lenalidomide maintenance by genetic profiling - an analysis of 556 Myeloma XI trial patients. Blood (2022)
Matthew W Jenner, Charlotte Pawlyn, Faith E Davies, Tom Menzies, Anna Hockaday, Catherine Olivier, John R Jones, Kamuraj Karunanithi, Jindriska Lindsay, Bhuvan Kishore, Curly T C M Morris, Mark T Drayson, Martin F Kaiser, Roger G Owen, Walter Gregory, David A Cairns, Gareth J Morgan, Graham H Jackson, null null
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial. British journal of haematology (2022)
Charles Agbuduwe, Gulnaz Iqbal, David A Cairns, Tom Menzies, Janet Dunn, Walter Gregory, Martin F Kaiser, Roger Owen, Charlotte Pawlyn, J Anthony Child, Faith Davies, Gareth J Morgan, Graham H Jackson, Mark T Drayson, Supratik Basu
Clinical characteristics and outcomes of IgD myeloma: experience across UK national trials. Blood advances 6 (17) (2022)
Matthew W Jenner, Charlotte Pawlyn, Faith E Davies, Tom Menzies, Anna Hockaday, Catherine Olivier, John R Jones, Kamaraj Karunanithi, Jindriska Lindsay, Bhuvan Kishore, Curly T C M Morris, Mark T Drayson, Martin F Kaiser, Roger G Owen, Walter Gregory, David A Cairns, Gareth J Morgan, Graham H Jackson, null null
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial. British journal of haematology (2022)
Matthew W Jenner, Charlotte Pawlyn, Faith E Davies, Tom Menzies, Anna Hockaday, Catherine Olivier, John R Jones, Kamuraj Karunanithi, Jindriska Lindsay, Bhuvan Kishore, Curly T C M Morris, Mark T Drayson, Martin F Kaiser, Roger G Owen, Walter Gregory, David A Cairns, Gareth J Morgan, Graham H Jackson, null null
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial. British journal of haematology (2022)
Graham H Jackson, Charlotte Pawlyn, David A Cairns, Ruth M de Tute, Anna Hockaday, Corinne Collett, John R Jones, Bhuvan Kishore, Mamta Garg, Cathy D Williams, Kamaraj Karunanithi, Jindriska Lindsay, Alberto Rocci, John A Snowden, Matthew W Jenner, Gordon Cook, Nigel H Russell, Mark T Drayson, Walter Martin Gregory, Martin F Kaiser, Roger G Owen, Faith E Davies, Gareth J Morgan, null null
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial. PLoS medicine 18 (1) (2021)
J R Jones, A Barber, Yann-Vaï Le Bihan, N Weinhold, Cody Ashby, Brian A Walker, Christopher Paul Wardell, H Wang, M F Kaiser, G H Jackson, F E Davies, R Chopra, Gareth J Morgan, Charlotte Pawlyn
Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs. Leukemia 35 (10) (2021)
Sarah Anne Bird, Charlotte Pawlyn, Susanna Nallamilli, Priya Sriskandarajah, Martin F Kaiser, Kwee L Yong, Rakesh Popat, Neil Rabin, Kevin D Boyd
A real-world study of panobinostat, weekly bortezomib and dexamethasone in a very heavily pretreated population of multiple-myeloma patients. British journal of haematology 191 (5) (2020)
Ceri A Bygrave, Charlotte Pawlyn, Faith Davies, Zoe Craig, David A Cairns, Anna Hockaday, Matthew Jenner, Gordon Cook, Mark Drayson, Roger Owen, Walter Gregory, Gareth Morgan, Graham Jackson, Martin F Kaiser
Early relapse after high-dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high-risk disease in multiple myeloma. British journal of haematology 193 (3) (2020)
Heinz Ludwig, Mario Boccadoro, Philippe Moreau, Jesus San-Miguel, Michele Cavo, Charlotte Pawlyn, Sonja Zweegman, Thierry Facon, Christoph Driessen, Roman Hájek, Melitios A Dimopoulos, Francesca Gay, Hervé Avet-Loiseau, Evangelos Terpos, Niklas Zojer, Mohamad Mohty, Maria-Victoria Mateos-Manteca, Hermann Einsele, Michel Delforge, Jo Caers, Katja Weisel, Graham Jackson, Laurent Garderet, Monika Engelhardt, Niels van de Donk, Xavier Leleu, Hartmut Goldschmidt, Meral Beksac, Inger Nijhof, Niels Abildgaard, Sara Bringhen, Pieter Sonneveld
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network. Leukemia 35 (1) (2020)
Graham H Jackson, Charlotte Pawlyn, David A Cairns, Alina Striha, Corinne Collett, Anna Waterhouse, John R Jones, Jamie Wilson, Craig Taylor, Bhuvan Kishore, Mamta Garg, Cathy D Williams, Kamaraj Karunanithi, Jindriska Lindsay, Matthew W Jenner, Curly T C M Morris, Nigel H Russell, Mark T Drayson, Martin F Kaiser, Roger G Owen, Walter M Gregory, Faith E Davies, Gareth J Morgan, null null
Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial. British journal of haematology 192 (5) (2020)
Charlotte Pawlyn, David A Cairns, Martin Kaiser, Alina Striha, John Jones, Vallari Shah, Matthew Jenner, Mark Drayson, Roger Owen, Walter Martin Gregory, Gordon Cook, Gareth Morgan, Graham Jackson, Faith Davies
The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial. Leukemia 34 (2) (2019)
Charlotte Pawlyn, Faith E Davies
Toward personalized treatment in multiple myeloma based on molecular characteristics. Blood 133 (7) (2018)
Eileen Mary Boyle, Cody Ashby, Christopher Paul Wardell, Dorota Rowczenio, Sajitha Sachchithanantham, Yan Wang, Sarah K Johnson, Michael A Bauer, Niels Weinhold, Martin F Kaiser, David C Johnson, John R Jones, Charlotte Pawlyn, Paula Proszek, Carolina Schinke, Thierry Facon, Charles Dumontet, Faith E Davies, Gareth J Morgan, Brian A Walker, Ashutosh D Wechalekar
The genomic landscape of plasma cells in systemic light chain amyloidosis. Blood 132 (26) (2018)
Charlotte Pawlyn, Andrea Loehr, Cody Ashby, Ruslana Tytarenko, Shayu Deshpande, James Sun, Kyle Fedorchak, Tariq Mughal, Faith E Davies, Brian A Walker, Gareth J Morgan
Loss of heterozygosity as a marker of homologous repair deficiency in multiple myeloma: a role for PARP inhibition? Leukemia 32 (7) (2018)
Charlotte Pawlyn, M D Bright, A F Buros, C K Stein, Z Walters, L I Aronson, Fabio Mirabella, J R Jones, M F Kaiser, B A Walker, G H Jackson, P A Clarke, Peter Leif Bergsagel, P Workman, M Chesi, G J Morgan, F E Davies
Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control. Blood cancer journal 7 (3) (2017)
V Shah, A L Sherborne, Brian A Walker, David C Johnson, E M Boyle, S Ellis, D B Begum, P Z Proszek, J R Jones, Charlotte Pawlyn, S Savola, M W Jenner, M T Drayson, R G Owen, R S Houlston, David A Cairns, W M Gregory, G Cook, F E Davies, G H Jackson, G J Morgan, M F Kaiser
Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients. Leukemia 32 (1) (2017)
J R Jones, D A Cairns, W M Gregory, C Collett, Charlotte Pawlyn, R Sigsworth, Alina Striha, R Henderson, M F Kaiser, M Jenner, G Cook, N H Russell, C Williams, G Pratt, B Kishore, J Lindsay, M T Drayson, F E Davies, K D Boyd, R G Owen, G H Jackson, G J Morgan
Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial. Blood cancer journal 6 (12) (2016)

Charlotte Pawlyn.css-eqlu8i{font-size:small;padding-left:4px;} (C Pawlyn)

Publication Activity (10 Years)

Top Topics

Top Venues

Charlotte Pawlyn (C Pawlyn)